We are live on
!
Find out more
OAG
Oakmont Advisory Group Portfolio holdings
AUM
$119M
This Fund
S&P 500
This Quarter
Est. Return
+11.54%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
+$20.9M
(+21%)
Cap. Flow
+$12.5M
Cap. Flow
% of AUM
10.46%
Top 10 Holdings %
Top 10 Hldgs %
40.31%
Holding
513
New
390
Increased
74
Reduced
36
Closed
8
Avg Time Held
0.4
quarters
Top 10 Avg Time Held
1.8
quarters
Top 20 Avg Time Held
1.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FT Vest US Equity Buffer ETF March
FMAR
|
+$857K |
| 2 |
FT Vest US Equity Buffer ETF May
FMAY
|
+$855K |
| 3 |
FT Vest US Equity Buffer ETF April
FAPR
|
+$836K |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$774K |
| 5 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$700K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FT Vest US Equity Buffer ETF November
FNOV
|
+$747K |
| 2 |
FT Vest US Equity Buffer ETF January
FJAN
|
+$746K |
| 3 |
FT Vest US Equity Buffer ETF December
FDEC
|
+$745K |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$578K |
| 5 |
Hims & Hers Health
HIMS
|
+$564K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.33% |
| 2 | Technology | 5.39% |
| 3 | Healthcare | 4.59% |
| 4 | Consumer Staples | 2.56% |
| 5 | Consumer Discretionary | 1.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SOLS
476
Solstice Advanced Materials
SOLS
$9.17B
| $616 | ﹤0.01% |
+7
| New | +$577 |
2026 Q2
0 quarters
|
|
477
iShares US Treasury Bond ETF
GOVT
$41.2B
| $590 | ﹤0.01% |
+26
| New | +$592 |
2026 Q2
0 quarters
|
|
478
Celanese
CE
$4.85B
| $587 | ﹤0.01% |
+13
| New | +$752 |
2026 Q2
0 quarters
|
|
479
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$456M
| $578 | ﹤0.01% |
+15
| New | +$603 |
2026 Q2
0 quarters
|
|
480
Guidewire Software
GWRE
$12.5B
| $497 | ﹤0.01% |
+4
| New | +$533 |
2026 Q2
0 quarters
|
|
481
Takeda Pharmaceutical
TAK
$57.1B
| $497 | ﹤0.01% |
+31
| New | +$513 |
2026 Q2
0 quarters
|
|
482
iShares 7-10 Year Treasury Bond ETF
IEF
$41.1B
| $492 | ﹤0.01% |
+5
| New | +$473 |
2026 Q2
0 quarters
|
|
483
Option Care Health
OPCH
$3.39B
| $462 | ﹤0.01% |
+22
| New | +$512 |
2026 Q2
0 quarters
|
|
484
Adobe
ADBE
$94.5B
| $410 | ﹤0.01% |
+2
| New | +$474 |
2026 Q2
0 quarters
|
|
485
Ingersoll Rand
IR
$29.5B
| $410 | ﹤0.01% |
+5
| New | +$387 |
2026 Q2
0 quarters
|
|
486
Amdocs
DOX
$6.07B
| $404 | ﹤0.01% |
+8
| New | +$491 |
2026 Q2
0 quarters
|
|
|
AIV
487
Aimco
AIV
$280M
| $371 | ﹤0.01% |
+125
| New | +$479 |
2026 Q2
0 quarters
|
|
488
Kyndryl
KD
$2.52B
| $362 | ﹤0.01% |
+32
| New | +$399 |
2026 Q2
0 quarters
|
|
489
GE HealthCare
GEHC
$29B
| $321 | ﹤0.01% |
+5
| New | +$329 |
2026 Q2
0 quarters
|
|
490
Advance Auto Parts
AAP
$2.34B
| $311 | ﹤0.01% |
+5
| New | +$284 |
2026 Q2
0 quarters
|
|
491
Bio-Rad Laboratories Class A
BIO
$9.87B
| $294 | ﹤0.01% |
+1
| New | +$284 |
2026 Q2
0 quarters
|
|
492
Veralto
VLTO
$23.1B
| $266 | ﹤0.01% |
+3
| New | +$261 |
2026 Q2
0 quarters
|
|
|
FISV
493
Fiserv Inc
FISV
$23.6B
| $245 | ﹤0.01% |
+5
| New | +$279 |
2026 Q2
0 quarters
|
|
|
PSKY
494
Paramount Skydance Corp
PSKY
$10.7B
| $187 | ﹤0.01% |
+19
| New | +$200 |
2026 Q2
0 quarters
|
|
495
Sylvamo
SLVM
$1.29B
| $163 | ﹤0.01% |
+4
| New | +$162 |
2026 Q2
0 quarters
|
|
496
Organon & Co
OGN
$3.6B
| $161 | ﹤0.01% |
+12
| New | +$143 |
2026 Q2
0 quarters
|
|
|
VSNT
497
Versant Media Group
VSNT
$4.31B
| $143 | ﹤0.01% |
+4
| New | +$161 |
2026 Q2
0 quarters
|
|
|
AMRN
498
Amarin Corp
AMRN
$261M
| $80 | ﹤0.01% |
+5
| New | +$74 |
2026 Q2
0 quarters
|
|
499
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$229M
| $79 | ﹤0.01% |
+3
| New | +$99 |
2026 Q2
0 quarters
|
|
500
American Airlines Group
AAL
$8.57B
| $39 | ﹤0.01% |
+2
| New | +$27 |
2026 Q2
0 quarters
|
|
Similar funds
BCM
FA
DFC
VIP
RMF
AA
AW
BAM
Oakmont Advisory Group's Q2 2026 Portfolio in Review
As of Q2 2026, Oakmont Advisory Group held 513 positions worth $119M, up 21% from $98.2M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Oakmont Advisory Group deployed $12.5M of net new capital in Q2 2026, opening 390 new positions and adding to 74 existing holdings. Its largest new stake was FT Vest US Equity Buffer ETF March: 16,676 shares worth $871K.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 81% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Hims & Hers Health, an estimated $564K trimmed.
- Oakmont Advisory Group's largest Q2 2026 buy was FT Vest US Equity Buffer ETF March: 16,676 shares worth $871K.
- Oakmont Advisory Group added most to iShares Ultra Short Duration Bond Active ETF in Q2 2026, an estimated $774K increase.
- Oakmont Advisory Group's biggest Q2 2026 reduction was Hims & Hers Health, cutting an estimated $564K.
- Oakmont Advisory Group fully exited FT Vest US Equity Buffer ETF November in Q2 2026, selling an estimated $747K.
- Oakmont Advisory Group's ten largest holdings make up 40% of its $119M portfolio in Q2 2026.
- Oakmont Advisory Group opened 390 new positions and closed 8 in Q2 2026.
- Oakmont Advisory Group's portfolio value rose 21% quarter-over-quarter to $119M.
Based on Oakmont Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.